✦ LIBER ✦

Sitaxsentan Treatment for Patients With Pulmonary Arterial Hypertension Discontinuing Bosentan

✍ Scribed by Raymond L. Benza; Sanjay Mehta; Anne Keogh; E. Clinton Lawrence; Ronald J. Oudiz; Robyn J. Barst

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Bosentan Treatment in Children

✍ Joseph F. Standing 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

55: Incidence of abnormal liver function

✍ R.E. Girgis; A.M. Keogh; R.L. Benza; R. Naeije 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Treatment of Pulmonary Arterial Hyperten

✍ Robyn J. Barst; David Langleben; David Badesch; Adaani Frost; E. Clinton Lawrenc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Sitaxsentan: an endothelin-A receptor an

✍ D. S. O'Callaghan; S. P. Gaine 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Bosentan: A novel agent for the treatmen

✍ Dermot O'Callaghan; Sean P. Gaine 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Bosentan for the treatment of pulmonary

✍ O. Sitbon; M. Beghetti; J. Petit; L. Iserin; M. Humbert; V. Gressin; G. Simonnea 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB